Recent advancements in cancer research have brought to light exciting new possibilities in the realm of immunotherapy, particularly concerning pancreatic cancer. Led by Dr. Vinod Balachandran, a team at Memorial Sloan Kettering Cancer Center (MSK) has made groundbreaking discoveries related to the
The transformative potential of Artificial Intelligence (AI) in the field of therapeutics, particularly drug development, has been a topic of significant excitement and investment. However, despite the enthusiasm, tangible evidence of AI's success in revolutionizing drug development remains
Clinical trials are the backbone of medical advancements, but they face a persistent challenge: participant adherence. Non-adherence can skew results, impact outcomes, and undermine the effectiveness of health solutions. Enter digital adherence tools, which are revolutionizing the landscape by
The production of protein-based drugs is a cornerstone of modern medicine, offering treatments for a range of conditions from cancer to autoimmune diseases. Central to this process are Chinese hamster ovary (CHO) cells, which are widely used in the biotechnology industry for their ability to
Imagine a world where antibiotics are so precisely targeted that they only attack harmful bacteria, leaving beneficial microorganisms unharmed and reducing the risk of antibiotic resistance. This scenario may not be as far-fetched as it seems, thanks to the pioneering work of researchers at the
A phase 1 clinical trial has brought new hope for patients with B-cell lymphoma, a type of blood cancer, through an innovative cell-based immunotherapy. Researchers from Washington University School of Medicine in St. Louis, along with other collaborators, have explored the safety and potential
